Biphasic insulin aspart 30

insulin aspart, biphasic 30/70 · Novo Nordisk

Drug timelines are a Plus or Pro feature.

39 regulatory and trial events tracked for Biphasic insulin aspart 30, covering 2006-08-08 to 2023-11-02. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs [Phase 4]